A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Awarded 2 Multi-Year Listing Agreements By Two of Canada's largest Group Purchasing Organizations

AGORACOM
Oct 29, 2021 03:07PM
Icon agoracom VIDEO – Valeo Pharma Agreement Supports $30M Annual Revenue Target From Blood Thinner Product Alone

AGORACOM
Oct 13, 2021 04:01PM
Icon agoracom INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

AGORACOM
Oct 13, 2021 12:48PM
Icon agoracom Valeo Pharma Obtains Listings for Redesca from Two GPO Representing 700 Hospitals and Healthcare Facilities Across Canada

AGORACOM-KE
Oct 13, 2021 07:00AM
Icon agoracom Valeo Pharma Completes Negotiations with Pan-Canadian Pharmaceutical Alliance for Enerzair® Breezhaler® and Atectura® Breezhaler®

AGORACOM-KE
Oct 05, 2021 07:00AM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Asthma Drug In Partnership With Novartis Exceeds Company Expectations

AGORACOM
Sep 30, 2021 11:22AM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Blood Thinner Drug Already Exceeds Internal Expectations

AGORACOM
Sep 29, 2021 12:37PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Has Undergone Significant Transformation Over Past 12 Months

AGORACOM
Sep 28, 2021 01:43PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma Is A Commercial Stage, Revenue Generating Company With Q3 Revenue of $5.7M

AGORACOM
Sep 27, 2021 03:08PM
Icon agoracom VIDEO – Valeo Pharma (VPH:CSE) Reported Record Q3-21 Revenue of $5.7 million, up 280% over Q3-20

AGORACOM
Sep 23, 2021 05:00PM
Icon agoracom Valeo Pharma Announces Record Revenues and Gross Margins for its Third Quarter 2021

AGORACOM-KE
Sep 22, 2021 04:54PM
Icon agoracom Valeo Pharma To Report Third Quarter 2021 Results and Hold Investors Conference Call / Webcast

AGORACOM-KE
Sep 16, 2021 07:00AM
Icon agoracom END OF DAY ALERT: Valeo Pharma Inc. (VPH: CSE) (VPHIF: OTCQB) Up +20% On 1.1M Shares

AGORACOM-KE
Jul 23, 2021 04:20PM
Icon agoracom Valeo Pharma Announces Additional Provincial Reimbursement Coverage for Redesca™ and Redesca HP™

AGORACOM-KE
Jul 13, 2021 07:00AM
Icon agoracom VIDEO – Valeo Pharma (VPH:CSE) Reported Record Q2 Revenue of $2.65M, CEO Expects Q3 To Increase More Than 50%

AGORACOM
Jul 04, 2021 07:00PM
Icon agoracom Valeo Pharma Reports its Second Quarter 2021 Results and Highlights

AGORACOM-KE
Jun 29, 2021 07:54PM
Icon agoracom Valeo Pharma Closes $11.5 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

AGORACOM-KE
Jun 29, 2021 09:39AM
Icon agoracom Valeo Pharma to Report Second Quarter 2021 Results and Hold Investors Conference Call / Webcast

AGORACOM-KE
Jun 23, 2021 09:04AM
Icon agoracom VIDEO - Valeo Pharma (VPH:CSE) Drug Projected To Add $30M / Year Revenue Gets Ontario Public Drug Coverage

AGORACOM
Apr 29, 2021 05:13PM
Icon agoracom VIDEO - Valeo Pharma $VPH $VPHIF Hesperco™️ Capsules at Core of Montreal Heart Institute's Coronavirus Clinical Trial

AGORACOM
Feb 21, 2021 07:34PM
New Message